10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $275,012 | -27.4% | 4,925 | -27.5% | 0.01% | -33.3% |
| Q1 2023 | $378,926 | +36.8% | 6,792 | -10.6% | 0.02% | 0.0% |
| Q4 2022 | $276,980 | +20.4% | 7,601 | +151.9% | 0.02% | -6.2% |
| Q1 2022 | $230,000 | -25.8% | 3,018 | +45.0% | 0.02% | -33.3% |
| Q4 2021 | $310,000 | +17.9% | 2,082 | +15.1% | 0.02% | -11.1% |
| Q3 2021 | $263,000 | -29.3% | 1,809 | -4.8% | 0.03% | -40.0% |
| Q2 2021 | $372,000 | – | 1,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |